Browse
FDA applications
Approved and filed applications connected to their products and owning companies.
29,787 results
| Application | Applicant | Application number |
|---|---|---|
| BLA 103957 | CSL Behring LLC | BLA103957 |
| BLA 103960 | CSL Behring GmbH | BLA103960 |
| BLA 103964 | pharmaand GmbH | BLA103964 |
| BLA 103969 | ALK - Abello A/S | BLA103969 |
| BLA 103970 | ALK - Abello A/S | BLA103970 |
| BLA 103971 | ALK - Abello A/S | BLA103971 |
| BLA 103972 | ALK - Abello A/S | BLA103972 |
| BLA 103973 | ALK - Abello A/S | BLA103973 |
| BLA 103974 | ALK - Abello A/S | BLA103974 |
| BLA 103976 | Genentech, Inc. | BLA103976 |
| BLA 103979 | Genzyme Corporation | BLA103979 |
| BLA 103980 | Baxter Healthcare Corporation | BLA103980 |
| BLA 121559 | SANOFI-AVENTIS US | BLA121559 |
| BLA 125010 | Omrix Biopharmaceuticals Ltd | BLA125010 |
| BLA 125011 | GlaxoSmithKline LLC | BLA125011 |
| BLA 125019 | Acrotech Biopharma Inc. | BLA125019 |
| BLA 125020 | MedImmune, LLC | BLA125020 |
| BLA 125029 | Eli Lilly and Company | BLA125029 |
| BLA 125031 | Amgen Inc. | BLA125031 |
| BLA 125034 | California Department of Public Health (CDPH) | BLA125034 |
| BLA 125035 | Kamada Ltd. | BLA125035 |
| BLA 125036 | Astellas Pharma US, Inc. | BLA125036 |
| BLA 125039 | Takeda Pharmaceuticals U.S.A., Inc. | BLA125039 |
| BLA 125046 | Grifols Therapeutics LLC | BLA125046 |
| BLA 125057 | AbbVie Inc. | BLA125057 |
| BLA 125058 | BioMarin Pharmaceutical Inc. | BLA125058 |
| BLA 125062 | Octapharma Pharmazeutika Produktionsges.m.b.H. | BLA125062 |
| BLA 125063 | Takeda Pharmaceuticals U.S.A., Inc. | BLA125063 |
| BLA 125070 | CSL Behring AG | BLA125070 |
| BLA 125075 | Genentech, Inc. | BLA125075 |
| BLA 125077 | Instituto Grifols, S.A. | BLA125077 |
| BLA 125078 | CSL Behring LLC | BLA125078 |
| BLA 125083 | Hoffmann-La Roche Inc. | BLA125083 |
| BLA 125084 | ImClone LLC a wholly-owned subsidiary of Eli Lilly and Company | BLA125084 |
| BLA 125085 | Genentech, Inc. | BLA125085 |
| BLA 125089 | Sanofi Vaccines US Inc. | BLA125089 |
| BLA 125103 | Swedish Orphan Biovitrum AB (publ) | BLA125103 |
| BLA 125104 | Biogen Inc. | BLA125104 |
| BLA 125105 | Takeda Pharmaceuticals U.S.A., Inc. | BLA125105 |
| BLA 125106 | GlaxoSmithKline Biologicals | BLA125106 |
| BLA 125108 | Merck Sharp & Dohme LLC | BLA125108 |
| BLA 125109 | Emergent BioSolutions Canada Inc. | BLA125109 |
| BLA 125111 | Sanofi Vaccines Canada Ltd. | BLA125111 |
| BLA 125115 | CSL Behring GmbH | BLA125115 |
| BLA 125117 | BioMarin Pharmaceutical Inc. | BLA125117 |
| BLA 125118 | Bristol-Myers Squibb Company | BLA125118 |
| BLA 125122 | Merck Sharp & Dohme LLC | BLA125122 |
| BLA 125123 | Merck Sharp & Dohme LLC | BLA125123 |
| BLA 125126 | Merck Sharp & Dohme LLC | BLA125126 |
| BLA 125127 | GlaxoSmithKline Biologicals | BLA125127 |